Search
                    Depression Clinical Trials in Columbus, OH
A listing of 6  Depression  clinical trials  in Columbus, OH  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 6 of 6
        
        
    
                The city of Columbus, Ohio, currently has 6 active clinical trials seeking participants for Depression research studies. 
            
                        Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    Featured Trial
                
                Lose Weight with Tirzepatide
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
    Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    Featured Trial
                
                ASCVD A Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with ASCVD
    
    
                            Conditions: 
                                    
        
            
                        ASCVD A
                    
                                    
                        ASCVD
                    
                                    
                        Atherosclerotic Cardiovascular Disease (ASCVD)
                    
                                    
                        Atherosclerotic Cardiovascular Disease
                    
                                    
                        Atherosclerotic Cardiovascular Diseases
                    
                                    Featured Trial
                
                ASCVD B Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with ASCVD
    
    
                            Conditions: 
                                    
        
            
                        ASCVD B
                    
                                    
                        ASCVD
                    
                                    
                        Atherosclerotic Cardiovascular Disease
                    
                                    
                        Atherosclerotic Cardiovascular Disease (ASCVD)
                    
                                    
                        Atherosclerotic Cardiovascular Diseases
                    
                                    Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    
                
                                    Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
                                
            
            
        Recruiting
                            
            
                Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/19/2025
            
            Locations: The Ohio State University, Columbus, Ohio         
        
        
            Conditions: Treatment Resistant Depression
        
            
        
    
                
                                    A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
                                
            
            
        Recruiting
                            
            
                This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset and durability of antidepressant effects of VLS-01-BU versus placebo.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                08/05/2025
            
            Locations: The Ohio State University, Columbus, Ohio         
        
        
            Conditions: Treatment Resistant Depression
        
            
        
    
                
                                    A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
                                
            
            
        Recruiting
                            
            
                Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/24/2025
            
            Locations: The Ohio State University, Columbus, Ohio         
        
        
            Conditions: Treatment Resistant Depression
        
            
        
    
                
                                    The Mom and Infant Outcomes (MOMI) Study
                                
            
            
        Recruiting
                            
            
                The investigator's long-term goal is to mitigate pregnancy-related mortality (PRM) risk by systematically delivering integrated clinical and supportive care that is effective, equitable, and scalable. The investigator's central hypothesis is that the Multi-modal Maternal Infant Perinatal Outpatient Delivery System (MOMI PODS) will mitigate postpartum (PP) risk and reduce disparities in PP risk by improving biopsychosocial profiles and facilitating access to evidence-based clinical and supportive...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                All
            Trial Updated:
                05/13/2025
            
            Locations: The Ohio State University, Columbus, Ohio         
        
        
            Conditions: Postpartum Depression, Postpartum Anxiety, Cardiometabolic Syndrome
        
            
        
    
                
                                    Nurse Family Partnership for Women With Previous Live Births
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to test the Nurse Family Partnership (NFP) in mothers with previous live births (multiparous or multip individuals). The main aims are:
Specific Aim 1-Determine the effectiveness of NFP among multiparous women for reducing maternal morbidity and improving pregnancy outcomes.
Specific Aim 2-Determine the effectiveness of NFP among index children (child from pregnancy when mother was enrolled) of multiparous women for improving child outcomes.
Specific Aim 3 (...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                Between 16 years and 46 years
            Trial Updated:
                03/27/2025
            
            Locations: Nationwide Children's Hospital, Columbus, Ohio         
        
        
            Conditions: Pregnancy, High Risk, Child Development, Post Partum Depression
        
            
        
    
                
                                    Academic-Community EPINET (AC-EPINET)
                                
            
            
        Recruiting
                            
            
                The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month, randomized trial.             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 35 years
            Trial Updated:
                09/17/2024
            
            Locations: The Early Psychosis Intervention Center (EPICENTER) at Ohio State, Columbus, Ohio         
        
        
            Conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Major Depression With Psychotic Features, Bipolar Disorder With Psychotic Features
        
            
        
    1 - 6 of 6
            
            
        